Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
George Church
AddedMar 31, 2024
UpdatedJun 28, 2026
George Church

George Church

Founder, Kern Systems

CrunchbaseLinkedIn

George Church's Career

Kern Systems
Kern Systems

Brookline, MA, US

Founder
Editas Medicine
Editas Medicine

Cambridge, MA, US

Board Member· Board
Genomera
Genomera

Mountain View, CA, US

Board Member· Board
64x Bio
64x Bio

San Francisco, CA, US

Co-Founder
Arrived
Arrived

Cambridge, MA, US

Co-Founder
Tierra Biosciences
Tierra Biosciences

San Leandro, CA, US

Co-Founder
GRO Biosciences
GRO Biosciences

Boston, MA, US

Co-Founder
eGenesis
eGenesis

Cambridge, MA, US

Co-Founder
Inari Agriculture
Inari Agriculture

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

George Church's Career

Kern Systems
Kern Systems
Pre-Seed$150k102019Brookline, MA, US
Founder

Leadership at Kern Systems

Pradeep BuggaPradeep BuggaCEO
Henry LeeHenry LeeFounder

Similar to Kern Systems

CatalogCatalogBoston, MA, USData Storageest. 2016CatalogBoston, MA, US · est. 2016

Boston-based software company, Catalog, innovates in information storage and computation using synthetic biology.

Series B · $54.3M17
Switchback SystemsSwitchback SystemsSan Francisco, CA, USDNA Synthesisest. 2019Switchback SystemsSan Francisco, CA, US · est. 2019

Switchback Systems, a San Francisco-based software startup, specializes in efficient, scalable DNA synthesis platforms.

Seed · $7.1M14
Ansa BiotechnologiesAnsa BiotechnologiesEmeryville, CA, USDNA Synthesisest. 2018Ansa BiotechnologiesEmeryville, CA, US · est. 2018

Ansa Biotechnologies: Pioneering enzyme-based, efficient DNA synthesis.

Series A · $83.4M82
CacheCacheSan Francisco, CA, USBiotechest. 2021CacheSan Francisco, CA, US · est. 2021

Cache: A FinTech startup harnessing nucleic acids to pioneer precision medicine and biological computing.

Pre-Seed · $6M7
Editas Medicine
Editas Medicine
Public$931.6M2262013Cambridge, MA, US
Board Member· Board

Leadership at Editas Medicine

J. Keith JoungJ. Keith JoungBoard Member
David R. LiuDavid R. LiuBoard Member
Akshay VaishnawAkshay VaishnawBoard Member
Gilmore O’NeillGilmore O’NeillBoard Member
Feng ZhangFeng ZhangBoard Member
Meeta ChatterjeeMeeta ChatterjeeBoard Member
Genomera
Genomera
Seed$20k312010Mountain View, CA, US
Board Member· Board

Leadership at Genomera

Jonathan ZempelJonathan ZempelCo-Founder
Eric RiesEric RiesBoard Member
Greg BiggersGreg BiggersCo-Founder
Andrew FieldAndrew FieldCo-Founder
Eric RiesEric RiesBoard Member
64x Bio
64x Bio
Series A$59.6M302017San Francisco, CA, US
Co-Founder

Leadership at 64x Bio

Alexis RovnerAlexis RovnerFounder
Jeffrey WayJeffrey WayCo-Founder
David ThompsonDavid ThompsonCo-Founder
Pamela SilverPamela SilverCo-Founder

Similar to 64x Bio

SynviviaSynviviaBerkeley, CA, USBiopharmaceuticalsest. 2016SynviviaBerkeley, CA, US · est. 2016

Synvivia: Chemical control for cell behavior, optimizing biopharma production.

Angel · $375.9k5
WhiteLab GenomicsWhiteLab GenomicsParis, Paris, FRGenomic Therapiesest. 2019WhiteLab GenomicsParis, Paris, FR · est. 2019

AI-driven platform for faster genomic therapy development.

Seed · $10M33
Xcell BiosciencesXcell BiosciencesSan Francisco, CA, USCell Therapiesest. 2012Xcell BiosciencesSan Francisco, CA, US · est. 2012

Xcell Biosciences, a biotech firm, innovates vitro tech for capturing and analyzing cancer cells from patient samples.

Series B · $39.6M29
CellChorusCellChorusSouth San Francisco, CA, USCell Therapy, Vaccinesest. 2017CellChorusSouth San Francisco, CA, US · est. 2017

CellChorus: AI-driven platform for rapid cell therapy & vaccine development analysis.

Seed · $2.4M6
Arrived
Arrived
Pre-Seed$1M302019Cambridge, MA, US
Co-Founder

Leadership at Arrived

Barghavi GovindarajanBarghavi GovindarajanCo-Founder

Similar to Arrived

ArrivedArrivedSeattle, WA, USRental Propertyest. 2019ArrivedSeattle, WA, US · est. 2019

Arrived Homes: Simplifying rental home investments with share purchases, property management, and passive income.

Pre-Seed · $163.4M66
ArrivedArrivedInvestments, Rental PropertyArrived

Arrived is a platform for investing in equity shares of rental homes, starting from $100.

Pre-Seed · $20k
WanderJauntWanderJauntSan Francisco, CA, USProperty Management, Softwareest. 2016WanderJauntSan Francisco, CA, US · est. 2016

WanderJaunt: Global tech-enabled property management for travelers and homeowners.

Series B · $26M175
AgentRouterAgentRouterLas Vegas, NV, USVacation Rentalsest. 2020AgentRouterLas Vegas, NV, US · est. 2020

VacationHomeRents: Compare & book rental homes, condos, and more for trips.

Pre-Seed · $500k75
Tierra Biosciences
Tierra Biosciences
Series A$25.2M352015San Leandro, CA, US
Co-Founder

Leadership at Tierra Biosciences

Richard MurrayRichard MurrayCo-Founder
Michael NemzekMichael NemzekCEO
Zachary SunZachary SunCo-Founder
Corinna ChenCorinna ChenBoard Member
GRO Biosciences
GRO Biosciences
Series A$32.3M442016Boston, MA, US
Co-Founder

Leadership at GRO Biosciences

Rakhshita DharRakhshita DharBoard Member
Bruce BeutelBruce BeutelBoard Member
Nicole PaulkNicole PaulkBoard Member
Ross ThyerRoss ThyerCo-Founder
Christopher RobertsChristopher RobertsBoard Member
Christopher GreggChristopher GreggCo-Founder

Similar to GRO Biosciences

Grove BiopharmaGrove BiopharmaChicago, IL, USBiotherapeuticsest. 2020Grove BiopharmaChicago, IL, US · est. 2020

Grove: A preclinical biotech startup innovating biotherapeutics for unmet medical needs.

Seed · $10.5M8
Groove BiopharmaGroove BiopharmaSeattle, WA, USDrugs, Therapeuticsest. 2008Groove BiopharmaSeattle, WA, US · est. 2008

Groove Biopharma: Pioneering microRNA therapeutics for cancer, fibrosis, and infectious diseases.

Series B · $9.9M6
AI ProteinsAI ProteinsBoston, MA, USProtein Therapeuticsest. 2021AI ProteinsBoston, MA, US · est. 2021

AI Proteins: A biotech firm specializing in the design and engineering of synthetic mini protein therapeutics.

Series B · $18.2M44
ProFound TherapeuticsProFound TherapeuticsCambridge, MA, USTherapeuticsest. 2022ProFound TherapeuticsCambridge, MA, US · est. 2022

ProFound Therapeutics: Innovating impactful disease understanding and therapeutic creation.

Series A · $75M35
eGenesis
eGenesis
Series C$265M1052015Cambridge, MA, US
Co-Founder

Leadership at eGenesis

Isaac CiechanoverIsaac CiechanoverBoard Member
Bob MoreBob MoreBoard Member
Al WiegmanAl WiegmanBoard Member
Boris NikolicBoris NikolicBoard Member
Julie SunderlandJulie SunderlandBoard Member
Mike CurtisMike CurtisCEO

Similar to eGenesis

Mammoth BiosciencesMammoth BiosciencesSan Francisco, CA, USCrispr Productsest. 2017Mammoth BiosciencesSan Francisco, CA, US · est. 2017

Mammoth Biosciences: An American biotech firm innovating CRISPR products to improve lives.

Series D · $264.5M195
InGeneronInGeneronHouston, TX, USRegenerative Therapiesest. 2006InGeneronHouston, TX, US · est. 2006

InGeneron: A multinational biotech firm unlocking patient healing through innovative regenerative therapies.

Series D · $51M32
ExogenesisExogenesisBillerica, MA, USMedical Devicesest. 2005ExogenesisBillerica, MA, US · est. 2005

Exogenesis Corp., based in Billerica, US, develops and processes implantable medical devices.

Seed · $7.8M17
InscriptaInscriptaBoulder, CO, USGenome Engineeringest. 2015InscriptaBoulder, CO, US · est. 2015

Inscripta: Pioneering scalable digital genome engineering with an advanced, fully automated CRISPR-based platform.

Series A · $463.9M178
Inari Agriculture
Inari Agriculture
Series F$609M4652016Cambridge, MA, US
Board Member· Board

Leadership at Inari Agriculture

Ignacio MartinezIgnacio MartinezCo-Founder & CEO
Sophie VandebroekSophie VandebroekBoard Member
John CaseyJohn CaseyCo-Founder
Michael MackMichael MackBoard Member
Ponsi TrivisvavetPonsi TrivisvavetBoard Member
Rodolphe BarrangouRodolphe BarrangouBoard Member

Similar to Inari Agriculture

IndigoIndigoBoston, MA, USAgricultural Productsest. 2013IndigoBoston, MA, US · est. 2013

Based in Boston, Indigo Agriculture, Inc. enhances agricultural production globally through microbial and digital technologies.

Late Stage Private · $1.4B1.7k
Sound AgricultureSound AgricultureEmeryville, CA, USCrop Solutionsest. 2012Sound AgricultureEmeryville, CA, US · est. 2012

Sound Agriculture: Innovating crop solutions for climate-resilient farming and enhanced yields, US-based.

Series D · $170.4M168
Pairwise PlantsPairwise PlantsDurham, NC, USCrop Developmentest. 2017Pairwise PlantsDurham, NC, US · est. 2017

Pairwise Plants, LLC: A global agricultural firm specializing in developing new crop varieties.

Series B · $115M75
VoloAgri GroupVoloAgri GroupSouth San Francisco, CA, USAgriculture, Seedest. 2012VoloAgri GroupSouth San Francisco, CA, US · est. 2012

VoloAgri Group Inc.: Nationwide provider of management and financing solutions for agricultural companies.

Series A · $127M200

George Church's Co-Investors

Mario SchlosserMario SchlosserCo-invested · Orchid SeedAmjad MasadAmjad MasadCo-invested · Orchid SeedAnne WojcickiAnne WojcickiCo-invested · Orchid SeedBrian ArmstrongBrian ArmstrongCo-invested · Orchid SeedBalaji SrinivasanBalaji SrinivasanCo-invested · Orchid SeedDylan FieldDylan FieldCo-invested · Orchid SeedElad GilElad GilCo-invested · Orchid SeedFidji SimoFidji SimoCo-invested · Orchid Seed

George Church's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to George Church

Brian D. AtheyBrian D. AtheyCo-Founder · Phenomics HealthDavid A. SinclairDavid A. SinclairBoard Member · Life BiosciencesAndreas PlückthunAndreas PlückthunCo-Founder · MorphoSysJay ShendureJay ShendureBoard Member · Adaptive BiotechnologiesGeorge YancopoulosGeorge YancopoulosCo-Founder · Regeneron Ph